NCT03513549View on ClinicalTrials.gov

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

SuspendedOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

November 4, 2014

Primary Completion Date

February 28, 2027

Study Completion Date

September 30, 2027

Conditions
Agitation,Psychomotor
Interventions
DRUG

Loxapine 10 MG

Trial Locations (1)

27612

Pharmaceutical Research Associates, Inc, Raleigh

Sponsors
All Listed Sponsors
collaborator

Pharmaceutical Research Associates

OTHER

lead

Alexza Pharmaceuticals, Inc.

INDUSTRY